Studies with LB 46, a new beta-receptor blocking drug.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure; D002415:Cats; D004837:Epinephrine / Q000037:antagonists & inhibitors; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006633:Histamine Antagonists; D007082:Ileum / Q000187:drug effects*; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology*; D011817:Rabbits; D012702:Serotonin Antagonists; D013565:Sympatholytics / Q000008:administration & dosage / Q000494:pharmacology*
D006633:Histamine Antagonists; D007211:Indoles; D012702:Serotonin Antagonists; D013565:Sympatholytics; D001285:Atropine; D011433:Propranolol; D007545:Isoproterenol; D000109:Acetylcholine; D004837:Epinephrine